Relapse rates and associated risk factors following omalizumab treatment in adolescents with chronic spontaneous urticaria.


Caka C., Ocak M., Duran B. C., Soyer Ö., Sekerel B. E., Şahiner Ü. M.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, vol.36, no.10, 2025 (SCI-Expanded) identifier identifier